Procedure
infection, allergy, viral infection, autoimmune disease
INFLAMMATORY BOWEL DISEASE, ALLERGY, VIRAL INFECTION, INFECTION, PATHOLOGY, AUTOIMMUNE DISEASE
A total of 46 patients were included and divided into 2 groups, probiotics (n = 23) or placebo (n = 24) groups. The inclusion criteria were age 18 years or more, a positive leukocyte test in stool and a confirmed diagnosis of viral infection by FilmArray™ Multiplex PCR System from bioMérieux, Marcy l’Etoile, France. Patients were included after they provided informed consent.The exclusion criteria were the presence of known autoimmune disease or inflammatory bowel disease, under immunosuppressive treatment for a known pathology, a confirmed diagnosis of infection by bacteria and/or parasites in the multiplex PCR test whether associated or not associated with viral etiology, previous administration of antibiotic treatment or consumption of any probiotic in the preceding 7 days, known allergy to the probiotic containing 